Subtitle
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma
Subtitle
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma
Proto therapy Time
May 2016
Executive summary
A randomized trial comparing proton therapy with transarterial chemoembolization (TACE) for hepatocellular carcinoma, reported a trend toward improved local tumour control, progression-free survival, and significantly fewer hospitalization days after proton treatment.
Key content topics
Top cancer treatments
Related contents
Webinar
Phase III randomized trial of IMPT versus IMRT for the treatment of head and neck oropharyngeal carcinoma (OPC)
An Interview with Dr. Steven Frank
Steven
Frank
Proton Therapy Publication
June 2024
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)
Proton Therapy Publication
November 2023
Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
Proton Therapy Publication
March 2023
Proton versus photon radiation therapy: A clinical review.
Proton Therapy Publication
August 2022
Proton Beam Therapy for Esophageal Cancer.
Webinar
April 22, 2022
The State of Proton Therapy in the U.S.
James
Metz
Webinar
April 22, 2022
Expanding Proton Therapy to Community Oncology Practices
Barbara
McAneny
Webinar
December 2021
Ongoing Trials and Current Evidence for proton therapy
Daniela
Alterio
Proton Therapy Publication
July 2021
PBT in rectal cancer